DPP4 and neoplasm: We observed that CD26 was constantly present in the nucleus of CD26+ cancer cells and the nuclear translocation of CD26 from cell surface was augmented by the treatment with anti-CD26 monoclonal antibody with anti-tumor effect in epitope-specific manner.